tiprankstipranks
Advertisement
Advertisement
MBX Biosciences reports Q4 EPS (49c), consensus (63c)
PremiumThe FlyMBX Biosciences reports Q4 EPS (49c), consensus (63c)
2M ago
MBX Biosciences appoints Basbaum as Chief Business Officer
Premium
The Fly
MBX Biosciences appoints Basbaum as Chief Business Officer
2M ago
MBX Biosciences Advances Canvuparatide After Phase 2 FDA Meeting
Premium
Company Announcements
MBX Biosciences Advances Canvuparatide After Phase 2 FDA Meeting
2M ago
MBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair
PremiumCompany AnnouncementsMBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair
3M ago
MBX Biosciences appoints Laurie Stelzer to board of directors
Premium
The Fly
MBX Biosciences appoints Laurie Stelzer to board of directors
3M ago
MBX Biosciences price target raised to $88 from $77 at Guggenheim
Premium
The Fly
MBX Biosciences price target raised to $88 from $77 at Guggenheim
4M ago
MBX Biosciences management to meet with Truist
PremiumThe FlyMBX Biosciences management to meet with Truist
4M ago
MBX Biosciences price target raised to $50 from $45 at Stifel
Premium
The Fly
MBX Biosciences price target raised to $50 from $45 at Stifel
5M ago
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
Premium
The Fly
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100